We used a gene amplification strategy to analyze T -cell receptor (TCR) gene rearrangements in 185 specimens, including mycosis fungoides/Sezary syndrome (MF ISS), other cutaneous neoplasms, inflammatory dermatoses, reactive lymphoid tissues, and normal skin. Genomic DNA was extracted from lesional tissues and rearrangements of the TCRy chain gene were amplified using the polymerase chain reaction (PCR) with primers specific for rearrangements involving Vyl-8 or Vy9 gene segments. The resulting PCR products were then separated according to their nucleotide sequence as well as size by denaturing gradient gel electrophoresis (DGGE). Dominant clonal TCR-y gene rearrangements were detected in 61 of 68 MF ISS cases by PCRI DGGE. This sensitivity of 90% compared to a sensitivity of only 59% when dominant clonality was sought in 17 of these same cases by Southern blot analysis of TCR-P gene rearrangements. This difference in sensitivity was greatest in early, minimally infiltrated skin lesions. PCR/DGGE was also more sensitive than Southern blot analysis for detecting peripheral blood involvement in two cases of early MF. Among 12 additional specimens of suspected MF/SS, nine (75%) showed clonal TCR-y gene rearrangements by PCR/ DGGE including six of eight cases with a previously confirmed diagnosis of MF ISS and three of four cases without A s in other types of non-Hodgkin'S lymphoma, the diagnosis of mycosis fungoides/Sezary syndrome (MF ISS) [1 -4) has been aided by the detection of dominant clonal T-cell populations in biopsy specimens using Southern blot analysis of T-cell receptor (TCR) gene rearrangements [1, 5, 6) . Nevertheless, several features of this approach limit its usefulness (7) . These limitations include Manuscript received November 10, 1993 ; accepted for publication February 8, 1994 .
Reprint requests to: Dr. Gary S. Wood, Chief, Dermatology-11G(W}, Veterans Affairs Medical Center, 10701 East Boulevard, Cleveland, OH 44106 prior known MF/SS. Among 105 non-MF/SS specimens, dominant TCR-y gene rearrangements were detected in only six cases (6%). Four were diagnosed as chronic dermatitis and two were diagnosed as cutaneous lymphoid hyperplasia.
We conclude that the large majority of MF ISS cases, including patch phase disease, possess dominant clonal TCR-Y gene rearrangements. PCR/DGGE is more sensitive than Southern blot analysis for detecting dominant clonality and staging disease in patients with a confirmed diagnosis of MF / SS. However, because PCR/DGGE is sensitive enough to detect dominant TCR-y gene rearrangements in a subset of patients with chronic dermatitis, it cannot be used as the sole criterion for establishing a diagnosis ofT -cell lymphoma. As with other molecular biologic clonality assays, clinicopathologic correlation is essential. Nevertheless, the detection of dominant clonality in some cases of histologically nonspecific dermatitis allows the identification of a previously unrecognized subset of patients, i.e., those with "clonal dermatitis." It will be important to determine the long-term risk of MF ISS among these patients because our study indicated that MF ISS can sometimes present with lesions indistinguishable from clonal dermatitis. ] Invest Dermatol1 03: [34] [35] [36] [37] [38] [39] [40] [41] 1994 the requirement for at least 10 5 _10 6 cells for a single analysis, an interval of about one to two weeks necessary to complete the analysis, and frequent reliance on radiolabeled hybridization probes-all of which contribute to costs and overall inconvenience. Most importantly, the sensitivity limitations of Southern blot analysis make the analysis of lesions containing sparse lymphocytic infiltrates problematic because the tumor cell density in' these specimens is often too low to ensure against false negative results.
In an effort to address some of these limitations, various molecular biologic alternatives to routine Southern blot analysis of TCR gene rearrangements have been devised. Many of these methods have been reviewed individually elsewhere (7) . They generally involve the amplification of TCR-P or TCR-y gene rearrangements using polymerase chain reaction (PCR) techniques. In contrast to Southern blot analysis, which utilizes the configuration of rearranged V, D, and] gene segments as clonal markers, PCR-based methOds utilize nucleotide sequence at the junction of rearranged segments as markers of clonality. Unique sequences at these sites are created during the process of gene rearrangement due to the combination of variably sized, small exonucleolytic deletions of germline sequences at the ends of the rearranging segments and the insertion of short stretches of random nucleotides between the segments prior to their joining. The result is a novel sequence specific for an individual lymphocyte and any clonal progeny that may derive from that cell.
Although each PCR-based method has certain advantages over Southern blot analysis, most possess limitations of their own, involving one or more of the following factors: the need for working with RNA, which is more labile than DNA, the need for labor-intensive cloning and sequence analysis ofTCR gene rearrangements, and/or the need for radioisotopes and autoradiography. However, one method avoids these limitations. This method involves the amplification ofTCR-y gene rearrangements followed by the fractionation of the resulting PCR products by denaturing gradient gel electrophoresis (DGGE) [8] . The entire procedure has been referred to as PCR/DGGE analysis. It involves three main steps: 1) extraction of genomic DNA from patient specimens, 2) PCR-based amplification ofTCR-y gene rearrangements from the genomic DNA, and 3) fractionation of the resulting PCR products by DGGE.
Although in principle applicable to any TCR gene, the TCR-y gene is the best target for analysis by PCR/DGGE for several reasons. First, compared to other TCR genes, TCR-y is a relatively simple gene, consisting in the germline form of eight V gene segments, seven V pseudogene segments, and five J segments, of which Vy2-Vy5, Vy8-Vyll, ]yl, and ]y2 frequently participate in rearrangements [9 -12] . Furthermore, there is enough nucleotide sequence homology among various V region a.nd J segments to allo~ the design of a small number of consensus pnmers capable of amp Itfying most TCR-y gene rearrangements [8] [9] [10] [11] [12] . Because the Vy and ]y target sequences complementary to that of the primers of rearranged TCR-y genes are less than 500 bp apart within rearranged genes, genomic DNA can be used as the PCR substrate. This obviates the need for reverse transcription of mRNA, which generally has been used for the PCR-based amplification ofTCR-P gene rearrangements because the standard genomic Vp and Cp target sequences lie too far apart for efficient amplification [7] .
DGGE was initially developed for the analysis of point mutations because it separates double-stranded DNA fragments according to nucleotide sequence in addition to size [13] [14] [15] . This separation is accomplished by electropho~esis of fragments through a gel containing a urea/formamide gradient that results in their partial melting, and therefore reduced mobility, at a point in the gradient determined by the nucleotide sequence. If sufficient numbers of fragments have identical size and sequence, as is produced by PCR of TCR genes from the genomic DNA of a clone of T cells, they form a band visible under ultraviolet light after staining of the gel with ethidium bromide. On the other hand, heterogeneous fragments, as amplified from polyclonal cells, form only a diffuse smear. PCR/DGGE analysis typically requires only 2-3 d to complete, and. does not involve radioactive reagents. Standard size cutaneous pu:nch and shave biopsy specimens provide adequate tissue for anal- YSiS. In prior studies, it was established that the detection of a dominant clone in tissue specimens by PCR/DGGE correlated with the presence of a dominant clone as detected by Southern blot analysis [8] . Furthermore, it was shown that PCR/DGGE could detect a dominant clone constituting as little as 1.0 -0.1 % of the total cells in the sample [8] . This initial report focused primarily on T-cell lines, leukemias, and heavily-infiltrated biopsy specimens of T-cell lymphomas. The goal of the current study was to determine the utility of PCR/DGGE for the analysis of T-cell clonality specifically in cutaneous lymphoid infiltrates, to indicate the possible usefulness of this procedure for staging tumor distribution in estab-T-CELL RECEPTOR GENE IN CTCL 35 lished cases of lymphoma, and for assisting in the diagnosis of cases that are difficult to classify as either malignant or benign. Toward these ends, we have investigated the prevalence of clonal TCR-y gene rearrangements among MF ISS cases, compared the sensitivity ofPCR/DGGE to routine Southern blot analysis in a subset of these cases, and analyzed the clonality of a wide variety of mflammatory cutaneous T-cell infiltrates.
MATERIALS AND METHODS
Tissues Representative samples of skin, lymph node, and/or peripheral blood mononuclear cells were obtained from 185 cases: 68 patients with MF/SS, 12 patients with suspected MF/SS, and 105 patients with other diseases. The non-MF/SS specimens all contained lymphoid infiltrates and included nonspecific dermatitis (23 cases), cutaneous squamous cell carcinoma (20 cases), cutaneous basal cell carcinoma (10 cases), cutaneous B-cell lymphoma (10 cases), cutaneous lymphoid hyperplasia (nine cases), hyperplastic tonsils (three cases), psoriasis (three cases), pityriasis rubra pilaris (two cases), acute allergic contact dermatitis (two cases), hyperplastic lymph nodes (two cases), herpes zoster (two cases), drug eruptions (two cases), and one case each of arthropod reaction, lichenoid keratosis, granuloma annulare, cutaneous cryptococcosis, and cutaneous sinus histiocytosis with massive lymphadenopathy. Twelve cases of normal skin were also studied. These specimens consisted of 4-6-mm cutaneous punch biopsies,S mm X 10 mm cutaneous shave biopsies, 5-mm 3 portions of lymphoid tissue, or the mononuclear cells from 20 cm) of blood. These specimens were snap-frozen and stored at-70 · C as described previously [16] . In each case, the diagnosis was based on established clinicopathologic criteria [1, 2) . In addition, cryostat sections of cases of MF/SS, B-cell lymphoma, and cutaneous lymphoid hyperplasia were studied immunohistologically with an extensive panel of T-cell, B-cell and histiocytic antigens using a three-stage biotin-avidin immunoperoxidase technique as reported previously [16) . The minimum panel for MF/SS cases included CDla, CD2, CD3, CD4, CDS, CD7, CD8, CDllc, CD22, CD30, and K.i67. Some controls, including the epithelial neoplasms, were also studied using this antibody panel. MF ISS cases studied by Southern blot analysis were also stained additionally with anti -TCR-P antibody 8A3. The minimum panel for all other lymphoma and lymphoid hyperplasia cases included the MF/SS panel plus CD19, CD20, CD35, and immunoglobulin chains (kappa, lambda, mu, delta). In each case studied, the immunohistologic findings were characteristic for MF/SS, B-cell lymphoma, or cutaneous lymphoid hype.rplasia as described previously [1) . In addition, all cases of cutaneous lymphoid hyperplasia and cutaneous B-cell lymphoma were characterized by Southern blot analysis of immunoglobulin heavy-chain gene rearrangements using a J H probe as described previously [17) . A monoclonal pattern was observed in each case of B-celllymphoma but not in any case of lymphoid hyperplasia.
Southern Blot Analysis of TCR Gene Rearrangements DNA extraction, Southern blot hybridization, and autoradiography were performed using standard methods [18) with minor modifications. All MF ISS cases subjected to Souther~ blot analysis were studied with a TCR-P probe. Some were also studied uSlllg a TCR-y probe. The TCR-P probe consisted of combined JP, and JP2 probes. The JP, probe is a 550-bp XbaI fragment derived from DNA between the JP, and CPt regions. The JP2 probe is a 4.3-kb EcoRI DNA fragment containing the JP2 region [19) . The TCR-y probe is a 2.1-kbp Hi"dm fragment containing the Jy1 region (19) . Thermocycling conditions consisted of denaturation at 94 · C for 1 min, annealing at 55 · C for 1.5 min, and extension at 70 · C for 1.5 min. Initially 25 cycles were performed using a set of "outer" Vy and Jy consensus primers corresponding to conserved Vy and Jy sequences. A 10-1l1 portion. of first-round PCR products in fresh reagent buffer was then used as a target III a subsequent round ofPCR using a set of " inner" Vy andlyconsensus primers corresponding to conserved Vyand Jy sequences nested Il1SI~e the sequence.s complementary to the outer primer pair. The outer and Inner pmner pam used for the amplification of rearrangements involv~ng VY.1-8 are listed in Table 1 . For the amplification of rearrangements mvolvmg Vy9, the outer and IImer Vyl-8 primers were replaced by the single Vy9 primer also listed in Table I GAA GCT TCT AGC TIT CCT GTC TC 3'   5' CGT CGA CAA CAA GTG TTG TTC CAC 3 were approximately 420 bp. First-and second-round Vy9 PCR products were slightly smaller, measuring about 400 bp and 380 bp, respectively. Representative second-round Vy1-8 PCR products are illustrated in Fig 1. Selection of optimal primer sequences and PCR conditions including the first-roundjsecond-round strategy were determined empirically in prior studies using T-cell lines [8] . All PCR reactions in this study were performed using a Thermal Cycler (Perkin-Elmer, Norwalk, CT). DNA from each specimen was amplified at least twice to ensure that any band detected was likely to represent an actual clonal population rather than the chance amplification of a product from a single cell (81. Negative controls included PCR reactions containing all reagents except target DNA. Because our primers are specific for VYl-9 and Jyl-2, they do not allow amplification of rearrangements involving other TCR-y gene segments such as Vyl0, Vyl1, and other Jy segments.
DGGE DGGE was performed in an apparatus similar to one currently available from CBS Scientific Co., Inc. (Del Mar, CA) following procedures described by Myers et al (15] . PeR-amplified genomic TCR-y rearrangements were separated by electrophoresis at 60°C through a 6.5% polyacrylamide gel containing a 30-60% ureajformamide denaturing gradient as described previously [8) . The gels were then stained by immersion in 1 Jig/ml ethidium bromide for 15 min, after which gels were photographed 2 3 4 5 6 7 8 under 300 nm UV light. To eliminate the presence of faint, nonspecific bands sometimes noted in prior studies of polyelonal T-cell samples, an additional step of melting the PCR products at 95°C for 5 min and then reannealing at 60°C for 1 h was introduced prior to loading the samples onto the gels (8] . This resulted in diffuse smears without discrete bands in lanes containing polyclonal TCR-y PCR products (Fig 2) .
Technical Points Concerning PCR/DGGE Two important technical points emerged from these studies. First, cases con taining monoclonal T-cell 6) and Vy9 PCR products (fatles 7 -13) were subjected to DGGE, stained with ethidum bromide, and photographed using UV illumination. Lanes 1 -5 and 7 -12 contain diffuse smears lacking discrete bands. This is the typical result in the absence of detectable dominant TCR-y gene rearrangements. Lane 1, lesional skin, cutaneous lymphoid hyperplasia. Lane 2, lesional skin, B-cell lymphoma. Lanes 3 and 4, lesional skin and reactive lymph node, respectively, cutaneous lymphoid hyperplasia. Latle 5, lesional skin, cutaneous lymphoid hyperplasia. La/Ie 6, Vyl-8 carry-over negative control containing all reagents except target DNA. Lane 7, lesional skin, MF. Lanes 8 -1 0, two lesional skin specimens and peripheral blood mononuclear cells, respectively, MF . Lanes 11 and 12, two normal skin specimens. Latlt 13, Vy9 carry-over negative control. Latle 14, empty lane. Although the MF specimens were polyclonal for Vy9, they showed dominant clonal bands for Vyl-B (for example, see la" e 8 in Fig 3) . populations, as evidenced by Southern blot analysis of TCR-/l gene rearrangements showing only one or two rearranged bands, can exhibit more than cwo discrete bands by PCR/DGGE. Often this appears as one or two strong bands and one or more weaker bands. At present, the source of these additional weaker bands is unknown; however, they are not due to the fina l melting/reannealing step performed prior to loading denaturing gradient gels [8] . Some of these bands may be due to heteroduplexes arising from annealing together of single strands of DNA amplified from different clonal TCR-Y gene rearrangements. More likely, these bands reflect an oli goclonal T-cell background from which a dominant T-cell clone has emerged. Because of possible differences in the lesional density of these clones, only the most dominant one may be detectable by Southern blot ana lysis. Recently, we have used elution, cloning, and sequencing to show that the comigrating dominant bands present in paired PCR/DGGE analyses of specimens of CD30+ large cell lympho ma and lymphomatoid papulosis obtained from a single patient do in fact represent a monoclonal TCR-y gene rearrangement shared by both lesions [20] .
Second, althoug h the PCR/DGGE band position produced by a given sample is constant in different lanes of the same gel, it can vary somewhat among different gels. This is probably due to subtle technical differences that can occur with each separate PCR/DGGE ana lysis. To some degree, this issue can be addressed by electrophoresis in each gel of several standard fragments. Obviollsly, the best approach to this problem is that specimens to be compared should be analyzed side-by-side in the same gel, as represented in Fig 3. We found matching dominant clonal band patterns in four MF ISS . cases in which multiple specimens were analyzed by PCR/DGGE.
RESULTS

Analysis of MF ISS Specimens To determine whether PCRI
DGGE analysis can reliably detect the presence of dominant T-cell clonal populations in skin specimens considered to contain histologic features diagnostic of MF ISS, we analyzed tissues from 68 cases. Sixty-one of these (90%) showed discrete bands in PCRI DGGE analyses including 16 Vyl-8+Vy9+, 35 Vyl-8+Vy9and 10 Vyl-8-Vy9+ cases. Examples are illustrated in Fig 3. The presence of both Vy1-B and Vy9 rearrangements in a single case is due presumably to rearrangement of both TCR-y gene alleles. The seven specimens that fai led to show discrete bands showed only diffuse smears in PCR/DGGE analyses of both Vy1-B and Vy9 rearrangements.
In 17 of the 68 cases, Southern blot analysis of TCR-{3 gene rearrangements was also performed on the same tissues. Representative Southern blot results are illustrated in Fig 4, and a comparison between the results of TCR-y PCR/DGGE and TCR-{3 Southern blot analysis is presented in Table II along with details concerning the type of specimens analyzed. Dominant c10nality was detected by PCR/DGGE analysis in six of seven cases that were negative by South ern blotting. Table III compares the false-negative rates for these cwo molecular biologic assays in early versus advanced MF I SS. These data demonstrate that PCR/DGGE is more sensitive than Southern blot analysis for detecting dominant TCR gene rearrangements in early lesional tissues (patches and thin plaques). Specific examples are illustrated in Fig 5. We chose to compare PCR/DGGE analysis ofTCR-y gene rearrangements to Southern blot analys is of TCR-{3 gene rearrangements because Southern blot analysis of TCR-y gene rearrangements can sometimes produce false-positive results [21, 22] , because the TCR-{3 gene is the one that has been studied by Southern blot analysis most commonly in the published literature [7] , and because almost all cases of MF ISS exhibit TCR-{3 gene rearrangements and express the TCR-Q{3 heterodimer [23] . This was also true of the cases studied by Southern blot analysis in this series because they reacted with anti -TCR-{3 monoclonal antibody 8A3. Southern blot analysis of TCR-y gene rearrangements was performed in two of these MF JSS cases as well as in two cases each of psoriasis, normal skin, and reactive lymphoid tissues, and one case each of granuloma annulare and cutaneous B-ceillymphoma. None of these specimens exhibited detectable monoclonal TCR-y gene rearrangements. came from patients with a prior confirmed diagnosis of MF/SS . Whether or not there was a prior diagnosis of MF ISS, there was a strong correlation between dominant clonality and histology suspicious for MFjSS. Dominant clonality was found in 75 % of these patients (six of eight) with a history of MF ISS, and in the same percentage of these patients (three of four) without a history of MF/SS.
Analysis of Suspected
In four of the cases with prior MF JSS, diagnostic specimens containing neoplastic T cells (blood in three cases and a skin tumor in the fourth) were available for comparison with the non-diagnostic specimen from the same case. PCRjDGGE showed similar bands in the paired diagnostic specimens in three of these cases. The fourth showed discrete bands in both specimens of the pair (skin patch and tumor), although the bands were found in different positions within the gel. The precise explanation for this phenomenon is obscure, but changes in clonal TCR-y gene rearrangements over time have been observed in cases of aCllte lymphoblastic leukemia. In this situation, such changes have been attributed to derivation of the leukemia from a transformed lymphocytic precursor, with subsequent rearrangement of TCR-y genes in progeny ceJls [17] .
Overall, these cases demonstrated that in patients with a past history of MF ISS, the disease can recur as a clonal, histologically nondiagnostic, cutaneous T-cell infiltrate. These cases also sug- One percent Sezary cells were later identified in this patient's peripheral blood. Initial skin biopsies were interpreted as nonspecific, chronic spongiotic dermatitis. Although some subsequent skin biopsies were suggestive of MF/SS, they remained histologically nondiagnostic. Nevertheless, they all contained an infiltrate of CD4+ T cells, the majority of which were CD5-and CD7-. This phenotype is consistent with MF ISS but not inflammation [1, 5] . Furthermore, the dominant clonality pattern was consistent in multiple skin specimens. Based on these findings, we concluded that this patient had early MF/SS that presented as a clonal, cutaneous T-cell infiltrate indistinguishable histologically [1, 24, 25] ' it was not unexpected to observe an association between overt lymphomas and this clonal, nonspecific dermatosis. Although this patient's skin lesions cleared transiently in response to total skin electron beam radiation therapy, they recurred and proved refractory to subsequent topical and systemic therapy. The patient eventually died of sepsis. An autopsy was not performed.
Molecular Biologic Staging ofMF ISS by PCR/DGGE Anal-
ysis In addition to the information regarding tumor clone distribution obtained by PCR/DGGE analysis of multiple skin specimens as discussed above, we also studied extracutaneous tissues in four MF ISS cases. The peripheral blood of two stage Ib MF patients contained low numbers of circulating atypical lymphocytes but no/ rare Sezary cells. TCR-fi and TCR-y Southern blot analysis of these blood specimens were negative; however, both specimens were clonal by PCR/DGGE. A third patient with stage Ib MF and a cytologically normal peripheral smear lacked evidence of blood in-1 23 456 Figure 5 . Southern blot analysis showing an absence of detectable TCR-P gene rearrangements in MF cases that showed dominant TCR-y gene rearrangements by PCR/DGGE. Lalle 1, negative Southern blot analysis of lesional skin from patch-type MF (TCR-P probe, BglII digest). La.les 2 and 3, PCR/DGGE analysis of the same case as in lalle 1 shows a Vyl-8-pattern in morphologically normal peripheral blood (Iall e 2) and a Vy1-8+ pattern in the same skin specimen as in lan e 1 (Ialle 3). Lalle 4, negative Southern blot analysis of lesional skin from a MF tumor nodule (TCR-P probe, BglII digest). Latles 5 and 6, PCR/DGGE analysis of the same specimen as in lane 4 shows Vyl-S+ and Vy9-patterns, respectively. The difference in the number of germ line bands visible in lalles 1 and 4 is due to a polymorphism in the presence of Bg/II restriction sites. volvement by PCR/DGGE although her cutaneous MF patch lesions were positive. Similarly, a cytologically normal lyn:Ph node removed from a patient with stage Ia MF also lacked eVidence of involvement by PCR/DGGE although her cutaneous MF patches showed dominant clonality.
Analysis ofNoo-MF ISS SpeciIneos
To determine the clonal-. ty ofTCR-y gene rearrangements in non -T -cell lymphoma speci-:Uens we used PCR/DGGE to analyze the 105 biopsies of inflammatory dermatoses, cutaneous B-cell lymphoma, normal skin, and reactive lymphoid tissues listed in Materials and Methods. In the vast majority of cases (94%), Vyl-8 and Vy9 PCR l?roducts produced only a diffuse smear after DGGE, consistent With the absence of dominant T-cell clonal populations bearing Vyl-9/Jyl-2 rearrangements in these samples (Fig 2) . This included the cases of cutaneous squamous cell carcinoma and basal cell carcinoma selected for study based on the presence of a significant T-cell host response as assessed by immunohistology.
. Occult dominant TCR-y gene rearrangements were detected III only six specimens, including four cases of nonspecific dermatitis (hereafter referred to as "clonal dermatitis") and two cases of cuta-neoUS lymphoid hyperplasia (hereafter referred to as "clonal cutaneous lymphoid hyperplasia"). The nonspecific dermatitis group contained 23 cases characterized histopathologically by a superficial perivascular lymphocytic in~ltrat~ accompanied in ~ost cases .by variable degrees of spongiOSIS, epidermal hyperplaSia, and/or 111flammation at the epidermal-dermal interface. Overall, this dermatitis group contained one case with clonal Vyl-8 rearrangements and three cases with clonal Vy9 rearrangements. The cutaneous lymphoid hyperplasia group contained nine cases, incl~ding one case with clonal Vyl-8 rearrangements and one case With clonal Vy9 rearrangements.
In the six cases of clonal dermatitis and clonal cutaneous lymphoid hyperplasia, the Vyl-8 and Vy9 PCR pro.ducts formed reproducible discrete bands after DGGE; however, 111 a number of these cases, the bands obtained from Vy9 PCR products were rather faint. In general, amplification with the Vy9 primer is more likely to produce artifactual bands of low intensity because the number of TCR-y gene rearrangements containing a Vy9 segment in a polyclonal population of T cells will be fewer than those containing Vyl-8 segments. Consequently, a TCR-y gene rearrangement present in only one copy may conceivably amp~i~ to prod.uce a visible band in the gel. On the other hand, the ablhty to obtam the same faint bands in multiple amplifications of DNA from the present specimens suggests that this is not a sufficient explanation and the bands observed do arise from dominant T cells clones in the tissues.
DISCUSSION
In this study, we used PCR/DGGE analysis to determine the clonality of T cells in samples obtained from 185 individuals including 105 non-T-cell lymphoma patients representing a wide variety of diagnoses, 68 patients with MF ISS, and 12 patients with suspected MF/SS. Our findings indicate that the large majority of MF/SS cases (90%) contain clonal TCR-y gene rearrangements involving Vy1-9 and Jyl-2. Only seven of 68 MF/SS cases (10%) lacked detectable dominant clonal TCR-y gene rearrangements. Presumably these cases contained TCR-y rearrangements involving Vy genes not detectable with our primers, previously deleted Vyl-9 rearrangements, or germline TCR-y genes. Because there are at least two other known TCR-y V segments (Vyl0 and Vy11) [11] , it is probable that the future use ofPCR primers capable of amplifying rearrangements of these other Vy segments will result in an overall sensitivity exceeding the current 90% level. Use of primers to other Jy genes (JyP, JyP1 , and JYP2) may also increase the yield of positive results, although prior studies suggest that many TCR-y gene rearrangements in T-cell neoplasms involve Jy1 or Jy2, which are both detected by our Jy consensus primers [8] [9] [10] [11] . The relatively large proportion of MF/SS cases containing dominant TCR Vy9 gene T-CELL RECEPTOR GENE IN CTCL 39 rearrangements may be explained at least in part by the apparent preferential generation and selection of TCR-y gene rearrangements involving 3' V region genes such as Vy9 [26, 27] . This may also explain the predominance of dominant TCR Vy9 gene rearrangements among the six cases of clonal non-MF ISS specimens. It should be noted that despite negative findings in our cases of cutaneous B-cell lymphoma, the detection of dominant clonal TCR-y gene rearrangements cannot be used to infer T-cell lineage because some B-cell neoplasms can exhibit clonal TCR-y gene rearrangements [11] .
In this series of cases, which included mostly early skin lesions containing relatively sparse infiltrates, PCR/DGGE was considerably more sensitive than Southern blot analysis for detecting dominant clonal TCR gene rearrangements in early MF ISS. Comparable levels of sensitivity for detecting clonality in MF/SS have been Table II , six of 17 MF ISS cases studied by both Southern blot and PCR/DGGE were shown to contain dominant T-cell clones only by PCR/DGGE. In many of these cases, the specimens analyzed were minimally infiltrated lesions characteristic of early disease (Tables II and III ). These findings indicate that PCR/DGGE will be superior to Southern blot analysis for staging MF ISS patients and monitoring their response to therapy. This conclusion is also supported by the ability of PCR/DGGE to identify the MF ISS dominant clonal pattern in histologically equivocal specimens from known MF/SS patients and its superior sensitivity in our initial staging investigations.
In addition, these findings are consistent with the view that histologically recognizable patch-type MF is a monoclonal disorder. They suggest that the failure of Southern blot analysis to detect monoclonality in some prior studies of patch-type MF [28, 29] was due to the limited sensitivity of this technique rather than to the absence of a monoclonal tumor cell population within the lesions. The increased sensitivity ofPCR/DGGE analysis relative to Southern blot analysis may derive both from its applicability to smaller absolute numbers of lymphocytes and from its ability to detect a clonal fraction of lymphocytes about tenfold lower than Southern blotting [8] .
Our current data also offer insights into the clonality of T-cell populations in normal skin, reactive lymphoid tissues, a wide variety of inflammatory dermatoses, and the host response to tumors. In the vast majority of these non-MF/SS specimens (99 of 105 or 94%), we were able to detect only polyclonal TCR-y gene rearrangements, supporting the polyclonal nature of T cells in these samples. Nevertheless, six of our 105 non-T-cell lymphoma specimens (6%) contained evidence of dominant T -cell clonality. It is possible that the detection of discrete bands by PCR/DGGE in these six cases might have arisen from the fortuitous amplification of TCR-y genes in over-represented reactive T-cell clones; however, it is also possible that the dominant TCR-y gene rearrangements in some or all of these cases originated in occult neoplastic clones. It is noteworthy that the six clonal non-MF/SS cases were restricted to two general disease categories: nonspecific dermatitis (four cases) and cutaneous lymphoid hyperplasia (two cases). We felt it was important to study both of these disease categories because early MF/SS is sometimes difficult to distinguish from chronic der-matitis, and other cutaneous lymphomas are sometimes difficult to distinguish from cutaneous lymphoid hyperplasia [1-4J. A subset of cutaneous lymphoid hyperplasia cases have been shown previously to contain occult dominant B-cell or T-cell clones [1, [30] [31] [32] [33] [34] , and it is known that clonal TCR-y gene rearrangements can be present in both B-cell and T-cell lymphoma [1, [5] [6] [7] 11 ]. Therefore, it is possible that the two clonal cases of cutaneous lymphoid hyperplasia each harbored an occult neoplastic B-cell or T-cell clone bearing a TCR-y gene rearrangement. Several studies have now documented cases in which clonal cutaneous lymphoid hyperplasia has evolved into overt lymphoma, predominantly of B-cell type [1, [30] [31] [32] 34 ]. Furthermore, these same studies indicate that patients with clonal cutaneous lymphoid hyperplasia represent a recognizable subgroup that is at increased risk for the development of cutaneous B-celllymphoma.
In addition to clonal cutaneous lymphoid hyperplasia, there are other situations in which a clinically benign clonal disease has been associated with an increased risk of overt lymphoma. These include other forms of extranodal lymphoid hyperplasia, the so-called benign monoclonal gammopathies, lymphomatoid papulosis and angioimmunoblastic lymphadenopathy with dysproteinemia [24, 25, [35] [36] [37] . This relationship between clonal B-cell and T-cell processes and increased lymphoma risk suggests that patients with clonal dermatitis may also repre~e~t a subgroup that is at i~crea~ed risk for the development of chmcally overt lymphoprohferattve disorders such as MF ISS . This conclusion is supported by our data, which showed that previously undiagnosed MF ISS can present as apparent clonal dermatitis (see case ].1. above), and that a strong correlation exists between dominant c10nality and histologic features suspicious for MF ISS. This conclusion is also consistent with numerous anecdotal reports of MF ISS developing at sites of apparent chronic dermatitis [3,41. It is these observations that may account in part for the difficulty pathologists have encountered in developing minimal morphologic criteria for the diagnosis of early MF ISS, and the relatively high level of inter-and intra-observer variability involved in early MF ISS diagnosis [1,2,381. When considering the potential neoplastic significance of clonal dermatitis, it is also important to note that non-neoplastic lesions of allergic contact dermatitis, induced in two patients with active MF, did not contain dominant TCR-y gene rearrangements detectable by PCRI DGGE although their MF lesions did [Veelken H, Sklar}, Wood GS: Presence of malignant T cells in lesions of allergic contact dermatitis developing in patients with cutaneous T cell lymphoma (abstr). Immutlobio/186:152, 1992] .
In summary, our findings demonstrate that clonal TCR-y gene rearrangements are present in the large majority of MF ISS patients. This indicates that MF ISS is a clonal disorder even in its earliest recogniz.able phases. Furthermore, PCR/DGGE is more sensitive than Southern blot analysis ofTCR gene rearrangements for detecting dominant clonality and staging disease in patients with confirmed MF/SS. However, because PCR/DGGE is sensitive enough to detect clonal TCR-y gene rearrangements in a subset of patients with chronic dermatitis, it cannot be relied upon as the sole criterion for establishing an unequivocal diagnosis of T -cell lymphoma. As with other molecular biologic assays oflymphoid clonaIity, clinicopathologic correlation is essential. Nevertheless, the detection of dominant clonality in some cases of histologically nonspecific dermatitis allows the identification of a previously unrecogniz.ed subset of patients, i.e., those with "clonal dermatitis." It will be important to determine the long-term risk of MF ISS among these patients because our study indicates that MF ISS can sometimes present as apparent clonal dermatitis. C lose follow-up of these patients could allow the diagnosis oflymphoma to be made at the earliest possible time. This is important because some studies have suggested that appropriate therapy initiated early in the course of MF/SS may improve not only the initial complete response rate but also longterm freedom from relapse and possibly the chances for cure [39] [40] [41] . Furthermore, early stage of disease at the time of diagnosis is a consistently favorable prognostic variable associated with longer THE )OURNAL OF INVESTIGATIVE DERMATOLOGY median survival regardless of the specific type of treatment given [39] [40] [41] .
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